<DOC>
	<DOC>NCT00164281</DOC>
	<brief_summary>This is a randomized, blinded, two-arm comparative trial of continued versus limited isoniazid (INH) tuberculosis (TB) preventive therapy in HIV-infected adults in Gaborone and Francistown, Botswana. Subjects will be accrued over two years and followed for a minimum of 36 months.</brief_summary>
	<brief_title>Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana</brief_title>
	<detailed_description>Randomized, double blinded, two-arm comparative trial of continuous vs. limited isoniazid preventive therapy in HIV-infected adults in Gaborone and Francistown, Botswana. Subjects will be accrued over two years and followed for a minimum of 36 months.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>1. HIVinfected 2. Age &gt;=18 years 3. Tuberculin skin test positive or negative 4. Laboratory: Hemoglobin (Hgb) &gt;6.5 gm/dl; Neutrophil count &gt;1,000 cells/mm3; Platelets &gt;75,000/mm3; AST (SGOT) &lt;122 U/L; Creatinine &lt;1.5 mg/dl; Beta HCG = negative 5. Karnofsky performance status &gt;=60 6. Signed informed consent 1. History of TB in the last 3 years or current active TB 2. History of noncompliance to chronic therapies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>TB</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>INH</keyword>
	<keyword>Isoniazid</keyword>
	<keyword>Preventive therapy</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Botswana</keyword>
	<keyword>LTBI</keyword>
	<keyword>Latent TB Infection</keyword>
</DOC>